(Q36982644)

17 August 2017

1 reference

title

Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers (English)

1 reference

17 August 2017

0 references

cervix uterine cancer

1 reference

Cara M Martin

1

1 reference

17 August 2017

Louise Kehoe

series ordinal

2

1 reference

17 August 2017

Cathy O Spillane

series ordinal

3

1 reference

17 August 2017

John J O'Leary

series ordinal

4

1 reference

17 August 2017

1 January 2007

1 reference

Molecular Diagnosis and Therapy

17 August 2017

1 reference

17 August 2017

11

1 reference

17 August 2017

5

1 reference

17 August 2017

277-290

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03256249

17 August 2017

0 references

cites work

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Classification of papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Molecular biology of human papillomavirus infection and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Common fragile sites are preferential targets for HPV16 integrations in cervical tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Frequent gain of copy number on the long arm of chromosome 3 in human cervical adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Recent advances in array comparative genomic hybridization technologies and their applications in human genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Chromosomal imbalances in four new uterine cervix carcinoma derived cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Mapping common deleted regions on 5p15 in cervical carcinoma and their occurrence in precancerous lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Reduced Fhit expression in cervical carcinoma: correlation with tumor progression and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

A model-based approach to selection of tag SNPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Whole genome genotyping technologies on the BeadArray platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

SNP association studies in Alzheimer's disease highlight problems for complex disease analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Association of specific genotype and haplotype of p53 gene with cervical cancer in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Molecular basis for heterogeneity of the human p53 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Primary structure polymorphism at amino acid residue 72 of human p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Codon 72 polymorphism of the TP53 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Two polymorphic variants of wild-type p53 differ biochemically and biologically

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

The Fas counterattack: cancer as a site of immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Fas gene promoter -670 polymorphism (A/G) is associated with cervical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene-gene interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Interleukin-10 and Fas polymorphisms and susceptibility for (pre)neoplastic cervical disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

DNA methylation, methyltransferases, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

DNA microarray: a high throughput approach for methylation detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Methylation of p16INK4a is a non-rare event in cervical intraepithelial neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Assessment of gene promoter hypermethylation for detection of cervical neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Epigenetics of cervical cancer. An overview and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Methylation Patterns of Papillomavirus DNA, Its Influence on E2 Function, and Implications in Viral Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

DNA methyltransferase inhibitors and the development of epigenetic cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

cDNA array analysis of cytobrush-collected normal and malignant cervical epithelial cells: a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Gene expression profiling in cervical cancer: an exploration of intratumor heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

p16(INK4A) is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Molecular profiling of cervical neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Detection of cancer-related gene expression profiles in severe cervical neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Prolonged oral etoposide in recurrent or advanced non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Validating survivin as a cancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Effects of human papillomavirus type 16 oncoproteins on survivin gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Survivin stable knockdown by siRNA inhibits tumor cell growth and angiogenesis in breast and cervical cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Targeted therapy by disabling crossroad signaling networks: the survivin paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Celecoxib induces apoptosis by inhibiting the expression of survivin in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Expression of geminin as a marker of cell proliferation in normal tissues and malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

The expression of cyclooxygenase-2, VEGF and PGs in CIN and cervical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Transcriptional expression of the genes implicated in angiogenesis and tumor invasion in cervical carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

DNA replication in eukaryotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Geminin-Cdt1 balance is critical for genetic stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Derivation and function of small interfering RNAs and microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Sizing up miRNAs as cancer genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

c-Myc-regulated microRNAs modulate E2F1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

MicroRNA expression profiling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Patterns of known and novel small RNAs in human cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Proteomic patterns: their potential for disease diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Protein profiling of cervical cancer by protein-biochips: proteomic scoring to discriminate cervical cancer from normal cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Analysis of the in vitro synergistic effect of 5-fluorouracil and cisplatin on cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Analysis of differential protein expression by cisplatin treatment in cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Role of proteomics in translational research in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Plasma proteomic profiling for detecting and differentiating in situ and invasive carcinomas of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Killing the messenger: short RNAs that silence gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

RNA interference is mediated by 21- and 22-nucleotide RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Synthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Effective expression of small interfering RNA in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

RNA interference remarkably suppresses bcl-2 gene expression in cancer cells in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Sulindac induces specific degradation of the HPV oncoprotein E7 and causes growth arrest and apoptosis in cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Inhibition of the epidermal growth factor receptor increases expression of genes that stimulate inflammation, apoptosis, and cell attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Inhibition of telomerase RNA (hTR) in cervical cancer by adenovirus-delivered siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Suppression of telomerase activity and arrest at G1 phase in human cervical cancer HeLa cells by all-trans retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Inhibition of telomerase enhances apoptosis induced by sodium butyrate via mitochondrial pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256249

Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix.

21 January 2018

1 reference

12 December 2020

Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia

1 reference

12 December 2020

Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer

1 reference

12 December 2020

A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus

1 reference

12 December 2020

Initiating DNA synthesis: from recruiting to activating the MCM complex

1 reference

12 December 2020

Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.

1 reference

12 December 2020

Identification of cervical cancer markers by cDNA and tissue microarrays

1 reference

12 December 2020

Reduced accumulation of specific microRNAs in colorectal neoplasia

1 reference

12 December 2020

Evaluation of Fas gene promoter polymorphism in cervical cancer patients.

1 reference

12 December 2020

Identification and characterisation of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene

1 reference

12 December 2020

Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears

1 reference

12 December 2020

Biological evaluation of omega-(dialkylamino)alkyl derivatives of 6H-indolo[2,3-b]quinoline--novel cytotoxic DNA topoisomerase II inhibitors.

1 reference

12 December 2020

Enhanced expression of Mcm proteins in cancer cells derived from uterine cervix

1 reference

12 December 2020

Comparative genomic hybridization reveals non-random chromosomal aberrations in early preinvasive cervical lesions

1 reference

12 December 2020

Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target

1 reference

12 December 2020

Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear

1 reference

12 December 2020

Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma

1 reference

12 December 2020

Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis

1 reference

12 December 2020

Quantitation of CDC6 and MCM5 mRNA in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix

1 reference

12 December 2020

Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix

1 reference

12 December 2020

An association of DNMT3b protein expression with P16INK4a promoter hypermethylation in non-smoking female lung cancer with human papillomavirus infection

1 reference

12 December 2020

Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers

1 reference

12 December 2020

Detection of autoantibodies to survivin in cervical mucus from patients with human papillomavirus-associated cervical cancer and precursor lesions

1 reference

12 December 2020

Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas

1 reference

12 December 2020

Aberrant methylation during cervical carcinogenesis

1 reference

12 December 2020

Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis

1 reference

12 December 2020

Adenocarcinoma of the cervix

1 reference

12 December 2020

Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL.

1 reference

12 December 2020

Expression of topoisomerase II and Ki-67 in cervical carcinoma--clinicopathological study using immunohistochemistry

1 reference

12 December 2020

Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array

1 reference

12 December 2020

Comparison of chromosome 3p deletions between cervical precancers synchronous with and without invasive cancer

1 reference

12 December 2020

P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer

1 reference

12 December 2020

Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection

1 reference

12 December 2020

Silencing of antiapoptotic survivin gene by multiple approaches of RNA interference technology.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256249

1 reference

17 August 2017

1 reference